SOLIGENIX, INC. Investment Income, Interest
SOLIGENIX, INC. (SNGX) reported Investment Income, Interest of $486 for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2020-11-12
- SOLIGENIX, INC. investment income, interest for the quarter ending 2020-09-30 was $486.00, a 98.69% decline year-over-year.
- SOLIGENIX, INC. investment income, interest for the quarter ending 2020-06-30 was $2.02K, a 94.94% decline year-over-year.
- SOLIGENIX, INC. investment income, interest for the quarter ending 2020-03-31 was $21.95K, a 50.96% decline year-over-year.
- SOLIGENIX, INC. investment income, interest for the quarter ending 2019-12-31 was $23.50K.
- SOLIGENIX, INC. investment income, interest for fiscal 2019 was $148.97K, a 6.05% decline from fiscal 2018.
- SOLIGENIX, INC. investment income, interest for fiscal 2018 was $158.57K.
- SOLIGENIX, INC. investment income, interest for fiscal 2014 was $1.31K, a 33.16% decline from fiscal 2013.
- SOLIGENIX, INC. investment income, interest for fiscal 2013 was $1.96K, a 68.40% decline from fiscal 2012.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2020-09-30 | $486.00 10-Q · filed 2020-11-12 | $2.50K derived: sum of 2 quarters · filed 2020-11-12 | $24.45K 10-Q · filed 2020-11-12 | $47.95K derived: sum of 4 quarters · filed 2020-11-12 |
| 2020-06-30 | $2.02K 10-Q · filed 2020-08-14 | $23.96K 10-Q · filed 2020-08-14 | $47.47K derived: sum of 3 quarters · filed 2020-08-14 | $84.47K derived: sum of 4 quarters · filed 2020-11-12 |
| 2020-03-31 | $21.95K 10-Q · filed 2020-05-15 | $45.45K derived: sum of 2 quarters · filed 2020-05-15 | $82.45K derived: sum of 3 quarters · filed 2020-11-12 | $122.31K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-12-31 | $23.50K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $60.51K derived: sum of 2 quarters · filed 2020-11-12 | $100.36K derived: sum of 3 quarters · filed 2020-11-12 | $148.97K 10-K · filed 2020-03-30 |
| 2019-09-30 | $37.01K 10-Q · filed 2020-11-12 | $76.86K derived: sum of 2 quarters · filed 2020-11-12 | $125.47K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $39.85K 10-Q · filed 2020-08-14 | $84.60K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $44.75K 10-Q · filed 2020-05-15 | |||
| 2018-12-31 | $158.57K 10-K · filed 2020-03-30 | |||
| 2014-12-31 | $1.31K 10-K · filed 2015-03-25 | |||
| 2014-03-31 | $291.00 10-Q · filed 2014-05-12 | $813.00 derived: sum of 2 quarters · filed 2015-03-25 | $1.47K derived: sum of 3 quarters · filed 2015-03-25 | $1.77K derived: sum of 4 quarters · filed 2015-03-25 |
| 2013-12-31 | $522.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | $1.17K derived: sum of 2 quarters · filed 2015-03-25 | $1.48K derived: sum of 3 quarters · filed 2015-03-25 | $1.96K 10-K · filed 2015-03-25 |
| 2013-09-30 | $652.00 10-Q · filed 2013-11-12 | $955.00 derived: sum of 2 quarters · filed 2013-11-12 | $1.44K 10-Q · filed 2013-11-12 | $2.36K derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-06-30 | $303.00 10-Q · filed 2013-08-12 | $786.00 10-Q · filed 2013-08-12 | $1.70K derived: sum of 3 quarters · filed 2014-05-12 | $2.95K derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-03-31 | $483.00 10-Q · filed 2014-05-12 | $1.40K derived: sum of 2 quarters · filed 2014-05-12 | $2.65K derived: sum of 3 quarters · filed 2014-05-12 | $4.45K derived: sum of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | $918.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $2.17K derived: sum of 2 quarters · filed 2014-03-26 | $3.97K derived: sum of 3 quarters · filed 2014-03-26 | $6.20K 10-K · filed 2014-03-26 |
| 2012-09-30 | $1.25K 10-Q · filed 2013-11-12 | $3.05K derived: sum of 2 quarters · filed 2013-11-12 | $5.28K 10-Q · filed 2013-11-12 | $7.41K derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-06-30 | $1.80K 10-Q · filed 2013-08-12 | $4.03K 10-Q · filed 2013-08-12 | $6.16K derived: sum of 3 quarters · filed 2013-08-12 | $7.57K derived: sum of 4 quarters · filed 2013-08-12 |
| 2012-03-31 | $2.23K 10-Q · filed 2013-05-03 | $4.36K derived: sum of 2 quarters · filed 2013-05-03 | $5.77K derived: sum of 3 quarters · filed 2013-05-03 | $7.24K derived: sum of 4 quarters · filed 2013-05-03 |
| 2011-12-31 | $2.13K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $3.54K derived: sum of 2 quarters · filed 2013-02-26 | $5.01K derived: sum of 3 quarters · filed 2013-02-26 | $7.44K 10-K · filed 2013-02-26 |
| 2011-09-30 | $1.41K 10-Q · filed 2012-11-14 | $2.88K derived: sum of 2 quarters · filed 2012-11-14 | $5.32K 10-Q · filed 2012-11-14 | $9.27K derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $1.47K 10-Q · filed 2012-08-10 | $3.91K 10-Q · filed 2012-08-10 | $7.86K derived: sum of 3 quarters · filed 2012-08-10 | $12.64K derived: sum of 4 quarters · filed 2012-08-10 |
| 2011-03-31 | $2.44K 10-Q · filed 2012-05-14 | $6.39K derived: sum of 2 quarters · filed 2012-05-14 | $11.16K derived: sum of 3 quarters · filed 2012-05-14 | $14.14K derived: sum of 4 quarters · filed 2012-05-14 |
| 2010-12-31 | $3.95K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27 | $8.73K derived: sum of 2 quarters · filed 2012-03-27 | $11.71K derived: sum of 3 quarters · filed 2012-03-27 | $12.07K 10-K · filed 2012-03-27 |
| 2010-09-30 | $4.78K 10-Q · filed 2011-11-14 | $7.75K derived: sum of 2 quarters · filed 2011-11-14 | $8.12K 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $2.98K 10-Q · filed 2011-08-12 | $3.35K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |